نتائج البحث

AMP-activated protein kinase suppresses the in vitro and in vivo proliferation of hepatocellular carcinoma.

• Authors : Cheng J; Department of Internal Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.; Huang T

Subjects: Cell Proliferation*; AMP-Activated Protein Kinases/AMP-Activated Protein Kinases/AMP-Activated Protein Kinases/*metabolism ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*enzymology

• Source: PloS one [PLoS One] 2014 Apr 07; Vol. 9 (4), pp. e93256. Date of Electronic Publication: 2014 Apr 07 (Print Publication: 2014).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

75P PD-L1 expression and TMB guided first-line sintilimab monotherapy for advanced NSCLC in a multi-center, phase II umbrella trial (CTONG 1702)

• Authors : Liu, S-Y.M.; Zhou, Q.; Du, Y.

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 9, page 102654 ; ISSN 2059-7029

تفاصيل العنوان

194MO Phase II study of low-dose radiation (LDRT) plus durvalumab (D) and etoposide/platinum (EP) as first-line treatment in ES-SCLC (LEAD): Efficacy and safety results

• Authors : Zhang, Y.; Xie, Y.; Gong, Y.

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 9, page 102767 ; ISSN 2059-7029

تفاصيل العنوان

13P Tislelizumab (TIS) plus chemotherapy (chemo) with or without bevacizumab (beva) for patients with EGFR-mutated nonsquamous non-small cell lung cancer (nsq-NSCLC) after progression on EGFR tyrosine kinase inhibitor (TKI) therapy

• Authors : Han, B.; Zhong, H.; Guo, Q.

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 9, page 102592 ; ISSN 2059-7029

تفاصيل العنوان

139P Efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: A systematic review and network meta-analysis

• Authors : Han, Y.; Xiao, X.; Yao, S.

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 9, page 102726 ; ISSN 2059-7029

تفاصيل العنوان

65P Preliminary results of a phase II multicenter, open-label study of fruquintinib monotherapy as third-line treatment in advanced pancreatic cancer

• Authors : Guo, W.; Qiong, W.; Wang, Y.

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 9, page 102294 ; ISSN 2059-7029

تفاصيل العنوان

45O First-in-human study of ABSK061: A selective fibroblast growth factor receptor (FGFR) 2/3 inhibitor for treating patients with advanced solid tumors

• Authors : Zhu, J.; Song, Z.; Zhao, Y.

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 9, page 102274 ; ISSN 2059-7029

تفاصيل العنوان

Altered and allele-specific open chromatin landscape reveals epigenetic and genetic regulators of innate immunity in COVID-19

• Authors : Zhang, B.; Zhang, Z.; Koeken, V.A.C.M.

Subjects: Cancer Research; Topic 1: Genes; Cells and Cell-Based Medicine

تفاصيل العنوان

Type IV collagen-derived angiogenesis inhibitor: canstatin low expressing in brain-invasive meningiomas using liquid chromatography–mass spectrometry (LC-MS/MS)

• Authors : Pei, Jian; Li, Pei; Gao, Yun H. ...

Subjects: Cancer Research; Neurology (clinical); Neurology

• Source: Journal of Neuro-Oncology ; volume 161, issue 2, page 415-423 ; ISSN 0167-594X 1573-7373

تفاصيل العنوان

The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan

• Authors : Su, Y.-Y.; Chiang, N.-J.; Chang, J.S. ...

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 8, issue 1, page 100746 ; ISSN 2059-7029

تفاصيل العنوان